Impact of postdilation on intervention success and MACE

March 19, 2020

Impact of Postdilation on Intervention Success and Long-Term Major Adverse Cardiovascular Events (MACE) among Patients with Acute Coronary Syndromes

In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0564, Turan Erdo?an, Hakan Duman, Mustafa Çetin, Sava? Özer, Göksel Çinier, Ece Usta, Mustafa Usta and Tuncay K?r?? from the Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdo?an University, Rize, Turkey, Department of Cardiology, Recep Tayyip Erdo?an Education and Research Hospital, Rize, Turkey, Department of Cardiology, Kaçkar State Hospital, Rize, Turkey and the Department of Cardiology, Atatürk Education and Research Hospital, ?zmir Katip Çelebi University, ?zmir, Turkey consider the impact of postdilation on intervention success and long-term major adverse cardiovascular events (MACE) among patients with acute coronary syndromes.

Postdilation is frequently used during coronary interventions to prevent stent malapposition. Currently there are contradictory findings regarding the benefits of postdilation for both intraprocedural and long-term outcomes. We evaluated the impact of postdilation among patients who presented with acute coronary syndromes (ACS) and underwent percutaneous coronary interventions (PCI). A total of 258 consecutive patients who presented with ACS and underwent PCI were included in the study. The patients were followed up for 25±1.7 months for the occurrence of major adverse cardiovascular events (MACE). During follow-up, 65 patients (25.2%) had MACE. Among patients without MACE, intracoronary nitrate infusion was less frequently used (P=0.005), myocardial blush grade was higher (P <0.001) and a drug-eluting stent was more frequently used (P=0.005). No significant differences were noted between groups regarding the predilation, recurrent dilation, postdilation, and other angiographic characteristics. In multivariate analysis, female sex (P=0.047), myocardial blush grade (P=0.038), previous coronary artery disease (P=0.030), and peak troponin level (P=0.002) were found to be predictors of MACE. In patients who were treated with PCI for ACS, performing postdilation did not predict final Thrombolysis in Myocardial Infarction (TIMI) flow grade, corrected TIMI frame count, myocardial blush grade, or MACE.

CVIA is available on the IngentaConnect platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. CVIA is indexed in the EMBASE, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.
-end-


Cardiovascular Innovations and Applications

Related Cardiology Articles from Brightsurf:

Cardiology compensation continues to rise; new interventional measures reported
MedAxiom, an American College of Cardiology Company and the premier source for cardiovascular organizational performance solutions, has released its eighth annual Cardiovascular Provider Compensation and Production Survey.

50% drop in patients attending cardiology services during coronavirus lockdown
The number of NHS patients presenting to cardiology services for serious heart problems more than halved while the number of heart attacks diagnosed fell by 40% at one centre in Scotland during the coronavirus lockdown, finds research published in the online journal Open Heart.

American College of Cardiology issues clinical competencies for cardiovascular NPs, PAs
The American College of Cardiology has released the 2020 Clinical Competencies for Nurse Practitioners and Physician Assistants in Adult Cardiovascular Medicine, identifying the knowledge and skills that are important for nurse practitioners (NPs) and physician assistants (PAs) working in general cardiovascular medicine and cardiovascular medicine subspecialty areas.

Scientists find potential way to defuse 'time bomb' of cardiology
In a new study published in EBioMedicine, researchers at Western University and Lawson Health Research Institute use principles from cancer biology to demonstrate what might be causing aortic aneurysms and potentially how to treat them.

Multimodality imaging training for general and advanced cardiology fellowships
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp.

One-two punch helps solve greatest unmet need in cardiology
Combining a high-fat diet with a drug that raises blood pressure gave UT Southwestern researchers a 'two-hit' model, like a one-two punch to heart failure.

Digital, mobile advances will define future of cardiology
The future of cardiovascular care will be transformed by advances in artificial intelligence, digital health technology, and mobile as a means to prevent and treat heart disease, according to several review articles published today in a Journal of the American College of Cardiology Focus Seminar on the Future Technology of Cardiovascular Care.

St. Michael's Hospital cardiology team reports a world first
Interventional cardiologist Dr. Neil Fam of St. Michael's Hospital has performed a world-first procedure, which he described in the Feb, 26 issue of the Journal of the American College of Cardiology: Cardiovascular Interventions.

The 28th Great Wall International Congress of Cardiology, Beijing, China
The 28th Great Wall International Congress of Cardiology (GW-ICC), the Asia Pacific Heart Congress (APHC) 2017, and the International Congress of Cardiovascular Prevention and Rehabilitation 2017 is being held from October 12th to 15th at the China National Convention Center (CNCC), Beijing, China.

Large nuclear cardiology laboratory slashes radiation dose by 60 percent in 8 years
A large nuclear cardiology laboratory has slashed its average radiation dose by 60 percent in eight years, according to new research presented today at ICNC 2017 and published in JACC: Cardiovascular Imaging.

Read More: Cardiology News and Cardiology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.